"Really exciting preliminary results for Phase I #clinicaltrial for KAN-101 presented by @josephmurrayMD at #DDW2022. We get closer every day to a #pharm option for #celiacdisease treatment! #celiac #glutenfree #gluten"

KAN-101 - Anokion

May 23, 2022